{
    "Trade/Device Name(s)": [
        "Sofia Influenza A+B FIA on Sofia 2"
    ],
    "Submitter Information": "Quidel Corporation",
    "510(k) Number": "K162438",
    "Predicate Device Reference 510(k) Number(s)": [
        "K153012",
        "K131606",
        "K112177"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PSZ",
        "KHO"
    ],
    "Summary Letter Date": "March 13, 2017",
    "Summary Letter Received Date": "March 14, 2017",
    "Submission Date": "August 26, 2016",
    "Regulation Number(s)": [
        "21 CFR 866.3328"
    ],
    "Regulation Name(s)": [
        "Influenza virus antigen detection test systems"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Influenza A viral nucleoprotein antigen",
        "Influenza B viral nucleoprotein antigen"
    ],
    "Specimen Type(s)": [
        "Direct nasal swab",
        "Nasopharyngeal swab",
        "Nasopharyngeal aspirate/wash"
    ],
    "Specimen Container(s)": [
        "Transport media",
        "Reagent Tube",
        "Test Cassette"
    ],
    "Instrument(s)/Platform(s)": [
        "Sofia",
        "Sofia 2"
    ],
    "Method(s)/Technology(ies)": [
        "Immunofluorescence"
    ],
    "Methodologies": [
        "Antigen detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Instrument",
        "Cassette",
        "Tube",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Sofia Influenza A+B FIA assay on Sofia 2 for rapid detection of influenza A and B antigens using immunofluorescence.",
    "Indications for Use Summary": "Intended to aid in the rapid differential diagnosis of acute influenza A and B viral infections in symptomatic patients using nasal or nasopharyngeal specimens; not for detection of influenza C.",
    "fda_folder": "Microbiology"
}